The authors explore the potential of adeno-associated virus (AAV) vectors as versatile tools for targeted gene therapy (GT) in HCC. They encapsulate the multifaceted exploration of AAV vectors in HCC GT, underlining their transformative potential within the landscape of oncology and human health.
[Virology Journal]